Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

By afschroeder • October 24, 2025

Augustin M, Armstrong A, Issa NT, Petersen AS, von Eyben R, Festini T, Torres T. Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis. Dermatol Ther (Heidelb). 2025 Oct 23. doi: 10.1007/s13555-025-01563-3. Epub ahead of print. PMID: 41131441.

Tags: atopic dermatitis, Dermatology, lebrikizumab, Long-term disease management, Maintenance of efficacy, Matching-adjusted indirect comparison, Publications, Tralokinumab

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

Mayo T, Silverberg JI, Armstrong A, Guttman-Yassky E, Blauvelt A, Esdaile B, Kabashima K, Gooderham M, Kircik L, Schneider S, Bennike N, von Eyben R,[...]

Bidirectional risk between autoimmune blistering diseases and posttraumatic stress disorder

Kasperkiewicz M, Ludwig RJ, Curman P. Bidirectional risk between autoimmune blistering diseases and posttraumatic stress disorder. J Eur Acad Dermatol Venereol. 2025 Oct 17. doi:[...]

Biologic Therapies For Dermatologic Emergencies: A Comprehensive Review

Modanlo N, Cheng K, Nguyen MO, Truong A. Biologic Therapies For Dermatologic Emergencies: A Comprehensive Review. J Am Acad Dermatol. 2025 Oct 17:S0190-9622(25)03025-7. doi: 10.1016/j.jaad.2025.10.055.[...]